![](https://img.youtube.com/vi/KUkgTnzhq7w/0.jpg)
United by Purpose
Each of us plays a unique role in bringing our purpose to life.
![](https://img.youtube.com/vi/grLigJOp2hQ/0.jpg)
Sanofi X Paris 2024
We’re proud to be premium partner of Paris 2024.
Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.
About Us
![](/optim/dotcom/pages/images/our-company/our-strategy/herobanner-strategy-4_20230515142620.jpg?size=medium)
Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
77
Compounds in clinical development
28
Clinical trials in phase 3
Explore Career Opportunities
You'll be surprised what you can achieve at Sanofi. Discover your future here.
Our Latest Press Releases
April 26, 2024
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases
April 25, 2024
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
April 23, 2024
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
April 17, 2024
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis